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lavage (BAL) has a sensitivity of 43% to detect IPA (12 published studies
including 195 patients with histologically proven IPA). Current treatment of
IPA consists mainly of amphothericin B. Lung resection (LR) for IPA is
rarely considered because of fea .... of peri-operative bleeding and infection.
However. the current literature on LR for IPA (> 100 patients) shows an
acccptable complication ratc: blccding 7°,{,, air leak 4%, infection 3%,
surgery related mortality 1%, 3O-day mortality 9% and fungal relapse
10%. Analysis of 27 paticnts undergoing LR for IPA at our institution
rcvcaled: feasibility of LR irrespective of neutrophil- and platelet counts;
median duration ofoperation 120 min; median blood loss 300 ml; immediate
extubation in 96%; median ICU-stay I day; median duration of chest tube
drainage 2 days; secondary stemcell transplantation possible. Medium term
survival (12 months) was superior in patients undergoing LR compared to
patients with medical treatment alone.
Conclusion: lung resection should be considered in selected neutropenic
patients with invasive pulmonary aspergillosis.
521 - Are all chronic diseases infections?
ITuS46 I Granulomatous diseases: Crohn's disease and
sarcoidosis
F. EI-Zaatari
Baylor College ofMedicine, HOIlSlon, Texas, Ullited States
Background: Crohn's disease (CD) and sarcoidosis (SA) are idiopathic
granulomatous diseases that share many features with mycobacterial infec-
tions. Reports on the association with cell wall deficient (CWO) forms of
Mycobacterium avium subsp. paratuberculosis (Map) are controversial.
Objectives: To confirm/refute the hypothesis of Map involvement in CD
and SA.
Methods and: Results: Our group and others used tissue and serum samples
from CD, SA and control patients to analyze by: 1) advanced cultural
techniques, 2) mycobacteria-specific polymerase chain reaction (PCR)
assays, 3) immunoblotting against recombinant clones expressing Map-
specific 35K (p35) and mycobacteria-specific 36K (p36)-antigens, 4) a
novel in situ hybridization (ISH) technique, bascd on the IS900 (a Map-
specific) probe, that was developed specifically for the detection of CWO
forms of Map, and 5) the recent use of macrolides and anti-mycobacterial
drags therapies.
Results: 1 and 2) CWO mycobacterial cells, specifically Map, were isolated
and/or identified from tissue specimens ofCD and SA and from breast milk
ofpatients with CD; 3) the majority ofCD patients sera (75% of53) reacted
with both p35 and p36 molecules versus only 2% of 58 controls. All 7 SA
patients reacted with p36; 4) CWO Map can be seen deep in fibroblasts, and
in acute and chronic inflammatory cells of active CD intestinal tissues with
granulomas; and 5) long term remission (possibly cure) in an increasing
number of CD patients.
Condusion: All the above evidence would suggest a causal role for myco-
bacteria in both diseases and treatment studies with anti-mycobacterial drags
including macrolides are warranted.
523 - Bacterial ecology and disease - are ...
IWeSSI Probiotics and streptococcal tonsillitis
K. Roos
ENT-dep., Lundby Hospital, Goteborg, Sweden
The significance of the normal fiora for the protection against infection in an
ecologic nisch has lately attracted an increased interest.
In the upper respiratory tract, alpha-streptococci have been in the focus of
interest in this regard. A lower number of alpha-streptococci have been
found in patients with recurrent streptococcal pharyngotonsillitis compared
to healthy controls, but also in otitis-prone children compared to non-otitis
prone and in children with secretory otitis media compared to healthy
children. Certain alpha-streptococci have been shown to have growth
inhibitory activity against common pathogenes in the upper respiratory
tract in vitro. We have shown that patients recolonized with alpha-
streptococci with interfering activity against beta-streptococci group A,
get less recurrences of streptococcal tonsillitis than placebo treated patients.
We have also isolated alpha-streptococcal strains with growth inhibitory
activity against pathogenes of acute otitis media. A significandy higher
number of otitis-prone children recolonized with these strains were healthy
during a randomized controlled study compared to placebo treated.
Conclusions: The results of ecological recolonization studies, both in
patients with streptococcal pharyngotonsillitis and in children with recur-
rent acute otitis media, indicate an important principle and stress the
importance of a normal balance between microorganisms in the upper
respiratory tract. This fact can be used in the protection against renewed
infections by recolonization with selected alpha-streptococcal strains in
paticnts with a disturbed normal fiora.
IWeS71 Probiotics in He/icobacter pylori infections
M. R. Gismondo, H. Mombelli
L. Sacco Teachitlg Hospital, University ofMilatl, ftaly
Interference of normal fiora with pathogenic micro-organisms growth and
vimlence has a long history of empirical observations and. more recently
scientific evidence. Probiotics, particnlarly lactic acid bacteria (Lactobacillus
and Bifidobacterium spp), are known to inhibit the growth of a wide range
of intestinal pathogcns in man and animals. Hdicobacter pylori is a peculiar
gastrointestinal pathogen, able to colonise stomach and cause.' peptic ulcer
and gastritis in man. In vitro studies demonstrated a strain-dependent and
concentration-dependent inhibitory activity ofLactobacilli against H. pylori.
Animal studies using gnotobiotic murine model proved both prevention of
H. pylori infection by Lactobacillus salivarius administration and suppression
of H. pylori by Lactobacillus salivarius administration after infection. The
suppression is supposed to be lactic acid mediated, and these results were also
reproduced with L. acidophilus and confirmed in human trials by oral
administration of sumatant, though H. pylori suppression was temporary.
Since the treatment of H. pylori infection is limited by deleterious side
effects, acquisition ofresistance, and sometimes lack oferadication, the use of
probiotics in prevention or treatment of this disease seems a very attractive
alternativc.
IWeSSI Treatment of diarrhoea with probiotics
S. L. Gorbach
Tujis University School of Medicine, Boston, MA, United States
Lactobacillus GG (LGG), a strain ofL. casei sps rhamnosus, has been studied
extensively with over 100 publications involving adults and children. In 15
placebo-controlled studies of acute diarrhea in children, LGG has been
shown to shorten the duration and reduce the severity ofthe acute episode. In
addition, duration of rotavirus shedding in the stools was reduced. These
studies were reported from various countries, including Finland, Italy,
Estonia, Russia, Thailand, Pakistan, and Peru. Similar findings were
reported recently in a study done in 287 children with acute diarrhea
enrolled in 13 pediatric centers within 10 European countries under the
auspices ofESPGHAN. LGG versus placebo was incorporated in ORS (oral
rehydration solution). The LGG group had significant reductions in dura-
tion of diarrhea and length of hospital stay. Fewer cases of protracted
diarrhea (> 6 days) were also seen in the LGG group. In another trial of
children given antibiotics for various respiratory infections, LGG treatment
was associatcd with less diarrhea side effects than placebo (17% with LGG vs
48% with placebo). The incidence of traveler's diarrhea was cut by 47% by
taking LGG as prophylaxis in a study ofAmcricans traveling to developing
countries. Other studies have shown benefit with LGG in treating cases of
antibiotic-associatcd diarrhea and relapsing Clostridium difficile colitis. LGG
is currendy ingested by millions of consumers each day in 25 countries as
dairy products or medicaments. Its excellent safety record has been docu-
mented by ongoing surveillance studies.
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IWeS10 I Surveillance systems responding quickly to
epidemics
O. L. Heymann
World Health Oganizatiotl, Geneva, Switzerland
With continuing globalization in travel and trade, global epidemic surveil-
lance is essential to ensure international public health security, The key
components of global epidemic surveillance are; epidemic intelligence;
epidemic preparedness; co-ordination of epidemic response. Epidemic
intelligence (accurate and timely information) about important disease
outbreaks should be delivered systematically and rapidly to key professionals
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in international public health. This is achieved through: specialized surveil-
lance networks; outbreak verification.
The World Health Organization (WHO) recognizes the importance ofin
partners in global epidemic surveillance and seeks to identify more effective
ways of working with collaborating institutions. To this end the WHO
global epidemic surveillance team links with a number of international
networks for specific disease threats.
To investigate and follow up outbreak reports, an innovative mechanism
_outbreak verification - was established at WHO headquarters in early 1997.
Its aim is to improve epidemic disease control by actively collecting and
verifying information on reported outbreaks and informing key public
health professionals of confirmed and unconfirmed outbreaks which are
potentially ofinternational public health importance. Outbreaks are assessed
for their importance to international public health (an outbreak with
potential for international spread, a need for international response, or a
potential impact on international travel or trade). Active follow-up with
affected countries is undertaken to verify the existence of the epidemic, its
cause and the response being put in place. WHO offers assistance in all cases.
525 - Pathogenicity islands and other horizontal. , .
[WeS11 1How do we protect ourselves against an outbreak of
hemorrhagic fever
A. Vaheri
Department of Virology, Haartman Institute, University of Helsinki, Finland
Viral hemorrhagic fevers (VHFs) are caused by arenaviruses (Lassa fever,
South American HFs), filoviruses (Ebola, Marburg), bunyaviruses (Crim-
ean-Congo HF, HFRS, Rift Valley fever) and ftaviviruses (dengue HF,
yellow fever). VHFs are zoonoses, prime examples of emerging infectious
diseases, several with dramatic clinical course and high mortality. Only
CGHF and hantaviral HFRSs have known animal reservoirs in Europe but
VHFs may be acquired abroad or, very rarely, in a laboratory setting, or
from an imported animal. The dramatic nature of VHF outbreaks easily
generates excessive media attention. Some VHFs are considered potential
weapons of bioterrorism. Thus there is increasing awareness to develop
better means to manage and control VHFs. Much can be done. (i) National
guidelines. Here we should remember that person-to-person spread ofVHFs
requires direct contact (blood, excreta) and that ribavirin is effective against
several VHFs. (ii) Effective channels of communication. Internet services
currently include WHO Outbreak Verification List, ProMed, and Euro-
Surveillance; specialized net on-line journals such as "Emerging Infectious
Diseases" arc also useful. (iii) Increased preparedness for rapid diagnostics
and international outbreak response (task force). In the multinational
Europe, unlike at CDC in the US, the diagnostic facilities are still limited.
While both rapid and safe tests (PCR, strip tests) as well as reliable reference
tests and BSL-4 laboratories arc needed, the first thing to suspect is still
malaria. The "European Network for Diagnostics of Imported Viral
Diseases" has built a network of European laboratories working on diag-
nostics of imported, rare, and emerging viral infections.
IWeS131 Pathogenicity islands of gram-negative bacteria:
Functional and evolutionary aspects
J. Heesemann
Max von Pettenkofer-lnstitut, Munith, Germany
In the early years of Medical Microbiology pathogenic bacteria were
characterized phenotypically by one virulence factor (e.g. toxin). Later,
the high complexity and variability ofpathogenic bacteria became evident.
In analogy to evolution of antibiotic resistance, transposons, plasmids,
phages and large mobile chromosomally integrated units (phathogenicity
islands, PAl) have been identified as carriers of pathogenicity genes and
virulons. Human pathogenic and opportunistic Gram-negative bacteria are
frequently carriers of PAIs. A complete PAl is ftanked by short directed
repeats and carries genes for PAl mobility (e.g. integrase). Many PAIs consist
of several modules which encode for type III secretion systems, several
antihost effector proteins, adhesins, ferric iron uptake systems and carry
DNA regions ofphage or plasmid origin. Because oftheir mobility PAIs can
disseminate into diverse species and thus generate new pathotypes. For
Escherichia coli more than six PAIs have been identified. The PAl-pattern
determines the pathotype ofE. coli e.g. EHEC, EPEC. UTEC.lnterestingly,
the majority ofsttains isolated from blood culture or urine ofpatients carry
the PAl ofYersinia pestis (denoted as HPJ), In Salmonella enteriea SPI-l is
involved in intestinal invasion and SPI-2 in intracellular survival. The impact
of PaIs in evolution of Samonella, Yersinia and Escherichia coli will be
discussed.
IWeS14j Bacterial crosstalk: Interaction between Yerslnia and
its target cell
H. Wolf-Watz
Cell and Moletular Biology, Umea, Sweden Ullil'ersity
We are using Yersillia pseudotuberculosis as a model to understand the basic
mechanisms behind the cell-contact dependent induction and subsequent
polarized translocation of the effector proteins (Yops) into the cytosol of the
target cell. Y. pseudotuberculosis up-regulates Yop-expression after an inti-
mate contact between the pathogen and its target cell has been established.
This cross-talk involves also the Type III secretion machine. The transloca-
tion mechanism is polarized and is dependent on at least three proteins
Yopll, YopD and LcrV respectively. Our results suggest that the YopB.
YopD and LcrV are involved in forming a pore in the membrane of the
target cell. After translocation, the different Yop-effectors are targeted to
different regions of the eukaryotic cell. The protein-tyrosine phosphatase
YopH. showing high homology with eukaryotic PTPases. blocks immedi-
ate early phosphorylation signals after infection. YopH is targeted to
focaladhesions leading to disruption of these structures. YopE works in
concert with YopH and these two proteins are essential for the pathogen to
block phagocytosis. YopE possesses a GAP activity which inactivates
proteins of the Rho-family of small G-proteins leading to disruption of
cell's cytoskeleton.
[WeS151 Comparative and functional genomics of Neisseria
X. Nassif
INSERM U411, Fa(llite Necker-E,ifants Malades, Paris, Franu
Neisseria meningitidis (Nm), Neisseriagotlorrhoeae (Ng), and Neisseria lattamica
(NI) belong to the same genospecies. However, they express dramatically
different pathogenesis. Nm colonizes the nasopharynx and is responsible for
septicemia and meningitis, Ng gives rise to a localised infection, and NI has
never been associated to a disease and is therefore believed to be non
pathogenic. Considering that both Nm and Ng are human pathogens
which do not survive in the environment and which colonize and invade
mucosa at their port of entry, it is likely that they share common
characteristics which are not found in the non pathogenic Nl. Furthermore
N. meningitidis may express specific virulence factors responsible for the
bloodstream dissemination and the crossing ofthe blood brain barrier. These
properties of pathogenic Neisseria may be determined by specific chromo-
somal regions. To address this issue, we used a combination of both
subtractive hybridization and hybridization of DNA arrays to identify
chromosomal regions specific for Nm and common between Nm and
N.g. These experiments confirmed that Nm has specific chromosomal
regions and others which arc shared with Ng. An analysis of the content
of these regions as well as the consequences of the mutagenesis of some of
these regions will be presented and tested in several models believed to be
associated with virulence.
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1WeS20IHow to report susceptibility results to clinicians
R. Auckenthaler
University HospitalSu'itzerland
Susceptibility test determine the susceptibility ofbacteria against antibiotics.
They are necessary to detect acquired resistance. For the clinician the
development of resistance makes the adequate prescription of antibiotics
more difficult Historically susceptibility tests have been performed by disk
diffusion. Today they include disk diffusion, growth of bacteria at various
antibiotic concentration or direct determination of MIC. All methods
correlate presumed or calculated MIC to the in vivo activity, reporting
sensitive, intermediate or resistant strains predicting the likely probability of
clinical success. Susceptibility tests allow to 1) the adapted prescription of
antimicrobial agents for a precise pathogen, 2) to follow epidemiological
trends of resistance. useful for empirical therapy, 3) detection of multi-
resistant strains with risk of nosocomiJll dissemination.
